CD94/NKG2A, A Natural Killer cell inhibitory receptor heterodimer molecule, can inhibit CD8+ T cell function, and blocking NKG2A enhances the immune activity of NK cells and T cells in mice, thus improving the anti-tumor immune responses. This evidence concerns the gene KLRC1 and neoplasm.